Delta9-tetrahydrocannabinol suppresses macrophage costimulation by decreasing heat-stable antigen expression.
Delta9-tetrahydrocannabinol (THC) suppresses several immunologic functions of macrophages. The costimulatory activity of a THC-exposed macrophage hybridoma was investigated by its ability to elicit interleukin-2 secretion by a helper T cell hybridoma activated with immobilized monoclonal anti-CD3 antibody. THC added at culture initiation inhibited the T cell response in a dose-dependent manner. When the macrophages were fixed with paraformaldehyde before culture, THC had no effect on T cell stimulation. However, macrophages, which were preincubated with THC and then fixed, were impaired in delivering costimulatory signals to T cells cultured without THC. The drug's inhibitory effect on macrophage costimulatory activity was reversible. THC exposure also decreased macrophage expression of heat-stable antigen (HSA). Antibody blocking experiments showed that HSA expressed on the macrophages provided an important costimulatory signal, whereas B7-1 and B7-2 molecules had a minor role. Treatment of the macrophages with phosphatidylinositol-specific phospholipase C cleaved HSA, but not the transmembrane B7 molecules, from the cell surface. Similar to THC, enzyme treatment significantly diminished macrophage costimulatory activity, which was also reversible. After drug or enzyme removal, HSA expression returned to the control level by 4 h. Therefore, THC suppresses macrophage costimulatory activity by diminishing cell surface expression of HSA.
Department of Microbiology and Immunology, Medical College of Virginia/Virginia Commonwealth University, Richmond 23298, USA.
D J
DJ
Clements
M
M
Matveyeva
K L
KL
McCoy
D000911:Antibodies, Monoclonal / Q000494:pharmacology; D000941:Antigens / Q000096:biosynthesis* / Q000276:immunology; D018122:B7-1 Antigen / Q000276:immunology; D017252:CD3 Complex / Q000276:immunology; D013759:Dronabinol / Q000494:pharmacology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008264:Macrophages / Q000187:drug effects* / Q000276:immunology / Q000378:metabolism*; D043265:Phosphatidylinositol Diacylglycerol-Lyase; D054801:Phosphoinositide Phospholipase C; D012680:Sensitivity and Specificity; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology; D006377:T-Lymphocytes, Helper-Inducer / Q000187:drug effects / Q000276:immunology; D010738:Type C Phospholipases / Q000378:metabolism / Q000494:pharmacology
D000911:Antibodies, Monoclonal; D000941:Antigens; D018122:B7-1 Antigen; D017252:CD3 Complex; D007166:Immunosuppressive Agents; D013759:Dronabinol; D010738:Type C Phospholipases; D054801:Phosphoinositide Phospholipase C; D043265:Phosphatidylinositol Diacylglycerol-Lyase